342 related articles for article (PubMed ID: 2667784)
1. Hypercalcaemia of malignancy.
Kelly PJ; Eisman JA
Cancer Metastasis Rev; 1989 Jun; 8(1):23-52. PubMed ID: 2667784
[TBL] [Abstract][Full Text] [Related]
2. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
Ralston SH; Fogelman I; Gardiner MD; Boyle IT
Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.
Ralston SH; Fogelman I; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
Clin Sci (Lond); 1984 Feb; 66(2):187-91. PubMed ID: 6692653
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypercalcaemia of malignancy with clodronate.
Bonjour JP; Rizzoli R
Bone; 1991; 12 Suppl 1():S19-23. PubMed ID: 1835397
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of hypercalcaemia of malignancy.
Mundy GR
Clin Endocrinol (Oxf); 1985 Dec; 23(6):705-14. PubMed ID: 3006948
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and management of cancer associated hypercalcaemia.
Ralston SH
Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
[TBL] [Abstract][Full Text] [Related]
7. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA; Guise TA
Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
[TBL] [Abstract][Full Text] [Related]
9. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
[TBL] [Abstract][Full Text] [Related]
10. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of humoral hypercalcaemia of malignancy.
Ralston SH
Lancet; 1987 Dec; 2(8573):1443-6. PubMed ID: 2892002
[TBL] [Abstract][Full Text] [Related]
12. Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.
Ralston SH; Boyce BF; Cowan RA; Gardner MD; Dryburgh FJ; Boyle IT
Q J Med; 1986 Mar; 58(227):325-35. PubMed ID: 3016790
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcaemia and hypocalcaemia: finding the balance.
Body JJ; Niepel D; Tonini G
Support Care Cancer; 2017 May; 25(5):1639-1649. PubMed ID: 28078478
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
[TBL] [Abstract][Full Text] [Related]
15. [The significance of early diagnosis of cancer-related hypercalcaemia].
Radványi I; Csikós A; Balogh S
Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
[TBL] [Abstract][Full Text] [Related]
17. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
Mantzoros CS; Suva LJ; Moses AC; Spark R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
[TBL] [Abstract][Full Text] [Related]
18. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong.
Shek CC; Natkunam A; Tsang V; Cockram CS; Swaminathan R
Q J Med; 1990 Dec; 77(284):1277-85. PubMed ID: 2290921
[TBL] [Abstract][Full Text] [Related]
19. Twist on a classic: vitamin D and hypercalcaemia of malignancy.
Osorio JC; Jones MG; Schatz-Siemers N; Tang SJ
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170170
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy.
Firkin F; Seymour JF; Watson AM; Grill V; Martin TJ
Br J Haematol; 1996 Sep; 94(3):486-92. PubMed ID: 8790147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
